Search Results - "Nishigawa, Ryo"

Abstract CT258: EF-32 (TRIDENT): A pivotal randomized trial of radiation therapy concomitant with temozolomide +/- Tumor Treating Fields (TTFields) in newly diagnosed glioblastoma by Shi, Wenyin, Kleinberg, Lawrence, Jeyapalan, Suriya A., Goldlust, Samuel A., Nagpal, Seema, Combs, Stephanie E., Roberge, David, Nishigawa, Ryo, Grossman, Rachel, Glas, Martin

“…Purpose: Tumor treating fields (TTFields) is a non-invasive, loco-regional antimitotic treatment approved as a standard-of-care for newly diagnosed…”
Get full text

Phase III TRIDENT trial: Radiation and temozolomide +/- tumor treating fields in newly diagnosed glioblastoma by Shi, Wenyin, Kleinberg, Lawrence, Jeyapalan, Suriya A., Goldlust, Samuel Aaron, Nagpal, Seema, Reardon, David A., Combs, Stephanie E, Roberge, David, Nishigawa, Ryo, Glas, Martin

“…Abstract only TPS2580 Background: Tumor treating fields (TTFields) is a non-invasive, regional antimitotic treatment approved as a standard of care for…”
Get full text

CTNI-74. PHASE 3 TRIDENT TRIAL: CONCOMITANT RADIATION THERAPY (RT) AND TEMOZOLOMIDE +/- TUMOR TREATING FIELDS (TTFIELDS) IN NEWLY DIAGNOSED GLIOBLASTOMA by Shi, Wenyin, Kleinberg, Lawrence, Jeyapalan, Suriya A, Goldlust, Samuel, Nagpal, Seema, Combs, Stephanie E, Roberge, David, Nishigawa, Ryo, Grossman, Rachel, Glas, Martin

Get full text